title: [Organ-sparing therapy for testicular cancer].
abstract: BACKGROUND
  The therapy of malignant testicular neoplasms has always been characterized by a high degree of radicality. Thanks to a number of medical achievements the cure rate of testicular cancer has notably increased through the last decades. In the meanwhile the main focus is on reducing therapy load, scrutinizing radical orchiectomy as the only adequate therapy for the primary tumour.
  
  
  OBJECTIVE
  This article discusses the question, if and under which conditions an organ-sparing approach can be used appropriately in clinical practice.
  
  
  METHODS
  A selective literature search was performed in PubMed.
  
  
  RESULTS
  A set of data suggest that endocrine and exocrine function of the testis can be preserved using an organ-sparing approach and many patients could benefit regarding their quality of life, e.g., preserving the ability to father a child at least temporarily and avoiding the need for hormone substitution. Different from kidney tumors, precancerous lesions (testicular intraepithelia neoplasia, TIN) can almost inevitably be found in the surrounding tissue of testicular tumors. This has to be considered when making a decision in favor of an organ-sparing approach, because radiation therapy on the affected testis has to be performed after tumor resection. Despite the absence of prospective data, organ-sparing surgical tumor resection can be recommended in carefully selected patients.
  
  
  CONCLUSIONS
  After careful selection of patients, particularly young men can profit from an organ-sparing therapy regimen. Therefore, organ preservation should always be considered in the surgical treatment of testicular masses.
authors.affiliation: Klinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Prittwitzstraße 43, 89075, Ulm, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Breunig
authors.forename: M
authors.initials: M
authors.lastname: Schrader
authors.forename: A J
authors.initials: AJ
authors.lastname: Schrader
authors.forename: F
authors.initials: F
authors.lastname: Zengerling
mesh_terms: D006801:Humans; D008297:Male; D019060:Minimally Invasive Surgical Procedures / Q000379:methods*; D059351:Organ Sparing Treatments / Q000379:methods*; D058958:Organs at Risk / Q000601:surgery*; D020127:Recovery of Function; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000601:surgery*; D013521:Urologic Surgical Procedures, Male / Q000379:methods*